The Anti-BCMA Monoclonal Antibody (HDbs0016) is a cutting-edge tool developed for researchers working in the field of immunotherapy and oncology. BCMA, or B-cell maturation antigen, is a cell surface receptor that is highly expressed in multiple myeloma and other B-cell malignancies. This monoclonal antibody, derived from hybridoma technology, specifically targets the BCMA protein, allowing for precise detection and analysis in experimental settings.Validated for use in various applications, including flow cytometry and immunohistochemistry, the Anti-BCMA Monoclonal Antibody (HDbs0016) is a versatile and reliable reagent for studying BCMA expression in both normal and diseased cells.
Its high specificity and sensitivity make it an invaluable tool for investigating the role of BCMA in cancer progression and identifying potential therapeutic targets for novel treatment strategies.With the increasing interest in targeting BCMA for immunotherapy in cancer patients, the Anti-BCMA Monoclonal Antibody (HDbs0016) offers researchers a powerful tool to advance their understanding of BCMA biology and develop innovative approaches for treating BCMA-positive malignancies. Don't miss out on this essential reagent for your research endeavors in the exciting field of cancer immunotherapy.
Product Name:
BCMA Biosimilar Antibody (HDBS0016)
Size:
100 ug
Product SKU:
HDBS0016
Target:
BCMA
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
BlueBird HuC11D5.3 (bb2121)
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
